FDA and CMS Come Together Again
Greetings to all. It's been a long time since our last post, but The RPM Report is trying to double its efforts in posting some useful insight into FDA, CMS and health policy. So that means a post every six months...kidding.
I wanted to bring your attention to two events coming up powered by The RPM Report. The first is an audioconference on November 14 titled: "The State of FDA: Drug Reviews, Policy and the IoM Report." The conference call will feature former FDA policy czar Amit Sachdev, former Hill health advisor Steve Irizarry and yours truly. You can find out more at by clicking on this link.
The second event is the biggest health policy and regulation meeting on the drug industry in Washington, D.C.: The RPM Report's FDA/CMS Summit for Biopharma Executives. If you operate in th edrug industry and you are a decision maker, then you should attend, period. Last year featured CMS Administrator Mark McClellan, FDA Commissioner Andrew von Eschenbach and all of the key government figures that are critical to the way drug and biotech companies do business. This year features the same lineup. You even get a free iPod Nano if you register early enough (hurry up though).
Check both of these events out so you'll know more next time you go into a company meeting.
Greetings to all. It's been a long time since our last post, but The RPM Report is trying to double its efforts in posting some useful insight into FDA, CMS and health policy. So that means a post every six months...kidding.
I wanted to bring your attention to two events coming up powered by The RPM Report. The first is an audioconference on November 14 titled: "The State of FDA: Drug Reviews, Policy and the IoM Report." The conference call will feature former FDA policy czar Amit Sachdev, former Hill health advisor Steve Irizarry and yours truly. You can find out more at by clicking on this link.
The second event is the biggest health policy and regulation meeting on the drug industry in Washington, D.C.: The RPM Report's FDA/CMS Summit for Biopharma Executives. If you operate in th edrug industry and you are a decision maker, then you should attend, period. Last year featured CMS Administrator Mark McClellan, FDA Commissioner Andrew von Eschenbach and all of the key government figures that are critical to the way drug and biotech companies do business. This year features the same lineup. You even get a free iPod Nano if you register early enough (hurry up though).
Check both of these events out so you'll know more next time you go into a company meeting.
posted by Ramsey Baghdadi at 3:40 PM
0 comments
